News Legal Alert life sciences Publications
Monday August 1st, 2022
Sorry, this entry is only available in Polish.
Sorry, this entry is only available in Polish.
In July last year, we reported that due to ongoing discussions, the possibility of limiting the sale of energy drinks…
The hemp industry is not only one of the fastest growing in Poland, but also worldwide. New products made with…
General information CBD (cannabidiol) has been steadily gaining popularity for some years now, and the global CBD market is expected…
Nicotine pouches (which we wrote about in the report) are not covered by any specific regulations in Poland. In particular,…
We have been recommended as one of the best law firms in 14 categories by The Legal500 EMEA 2024 ranking,…
On March 21, 2023, the long-awaited act on clinical trials of medicinal products for human use was signed by the…
EU regulations on medical devices (MDR[1]) and in vitro diagnostic medical devices (IVDR[2]) have been applied for several years now…
The hemp market includes food products, cosmetic products, but also pharmaceutical raw materials or products for animals. What should an…
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of KO-MED Clinical Centers—one…
We are proud to announce that in this year’s edition of The Legal 500 we have been recommended in 13…
“SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Gliwcka Przychodnia Weterynaryjna”. One of the…
An updated guideline for borderline products has been published on the European Commission website. For many product categories (e.g. medical…
SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Centrum Zdrowia Małych Zwierząt” in Poznań,…
On January 1, 2024, an amendment to the Public Health Act entered into force, revolutionizing the energy drinks market in…
DISTRIBUTION Possible ’faster’ export/sale of products included on the list of products facing potential shortages in Poland. The Main Pharmaceutical Inspectorate (GIF) will be able…